AGIOS PHARMACEUTICALS INC COM USD0.001AGIOS PHARMACEUTICALS INC COM USD0.001AGIOS PHARMACEUTICALS INC COM USD0.001

AGIOS PHARMACEUTICALS INC COM USD0.001

No trades
See on Supercharts

0HB0 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in a research engine, multiple novels, and investigational therapies in preclinical development. It focuses on cellular metabolism and classical hematology. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
0HB0 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company